Omega-3 fatty acids protect from diet-induced obesity, glucose intolerance, and adipose tissue inflammation through PPARγ-dependent and PPARγ-independent actions

Molecular Nutrition and Food Research

Volumn 59, Issue 5, 2015, Pages 957-967

  Belchior, Thiago ^a   Paschoal, Vivian A ^a   Magdalon, Juliana ^a   Chimin, Patricia ^a   Farias, Talita M ^a   Chaves Filho, Adriano B ^a   Gorjão, Renata ^b   St Pierre, Philippe ^c   Miyamoto, Sayuri ^a   Kang, Jing X ^d   Deshaies, Yves ^c   Marette, André ^c   Festuccia, William ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

^c LAVAL UNIVERSITY   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adiposity; Glucose metabolism; Inflammation; Omega 3 polyunsaturated fatty acids; PPAR antagonism

Indexed keywords

MUS;

GLUCOSE BLOOD LEVEL; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOSE TISSUE; ANALYSIS; ANIMAL; C57BL MOUSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; LIPID DIET; MALE; MOUSE; OBESITY; PATHOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; FATTY ACIDS, OMEGA-3; GLUCOSE TOLERANCE TEST; MALE; MICE; MICE, INBRED C57BL; OBESITY; PPAR GAMMA;

EID: 84928671879     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400914     Document Type: Article

References (47)

1. Kahn, S. E., Hull, R. L., Utzschneider, K. M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444, 840-846.
2. Martínez, J. A., Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance. J. Physiol. Biochem. 2006, 62, 303-306.
3. Després, J.-P., Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur. Heart J. Suppl. 2006, 8, B4-B12.
4. Hotamisligil, G., Shargill, N., Spiegelman, B., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
5. Simopoulos, A., The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 2008, 233, 674-688.
6. Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O. et al., Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56, 1986-1998.
7. Hotamisligil, G. S., Erbay, E., Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 2008, 8, 923-934.
8. Adkins, Y., Kelley, D. S., Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J. Nutr. Biochem. 2010, 21, 781-792.
9. Serhan, C. N., Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014, 510, 92-101.
10. Calder, P., N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83.
11. Calder, P., Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013, 75, 645-662.
12. Kang, J., Wang, J., Wu, L., Kang, Z., Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427, 504.
13. Fiamoncini, J., Turner, N., Hirabara, S. M., Salgado, T. M. L. et al., Enhanced peroxisomal β-oxidation is associated with prevention of obesity and glucose intolerance by fish oil-enriched diets. Obesity 2013, 21, 1200-1207.
14. Li, J., Li, F. R., Wei, D., Jia, W. et al., Endogenous ω-3 PUFAs production confers resistance to obesity, dyslipidemia, and diabetes in mice. Mol. Endocrinol. 2014, 28, 1316-1328.
15. Romanatto, T., Fiamoncini, J., Wang, B., Curi, R., Kang, J. X., Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice. Biochim. Biophys. Acta 2013, 1842, 186-191.
16. Sun, H., Hu, Y., Gu, Z., Owens, R. et al., Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. Carcinogenesis 2011, 32, 1518-1524.
17. MacLennan, M., Clarke, S., Perez, K., Wood, G. et al., Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. J. Nutr. Biochem. 2013, 24, 388-395.
18. Bellenger, J., Bellenger, S., Bataille, A., Massey, K. et al., High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 2011, 60, 1090-1099.
19. Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142, 687-698.
20. Neuhofer, A., Zeyda, M., Mascher, D., Itariu, B. K. et al., Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 2013, 62, 1945-1956.
21. González-Périz, A., Horrillo, R., Ferré, N., Gronert, K. et al., Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009, 23, 1946-1957.
22. González-Périz, A., Planagumà, A., Gronert, K., Miquel, R. et al., Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 2006, 20, 2537-2539.
23. Sell, H., Habich, C., Eckel, J., Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 2012, 8, 709-716.
24. Nakano, R., Kurosaki, E., Yoshida, S., Yokono, M. et al., Antagonism of peroxisome proliferator-activated receptor γ prevents high-fat diet-induced obesity in vivo. Biochem. Pharmacol. 2006, 72, 42-52.
25. Rodbell, M., Metabolism of isolated fat cells. J. Biol. Chem. 1964, 239, 375-380.
26. Derogis, P. B., Freitas, F. P., Marques, A. S., Cunha, D. et al., The development of a specific and sensitive LC-MS-based method for the detection and quantification of hydroperoxy- and hydroxydocosahexaenoic acids as a tool for lipidomic analysis. PLoS One 2013, 8, e77561.
27. Masood, A., Stark, K. D., Salem, N., A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. J. Lipid Res. 2005, 46, 2299-2305.
28. Weischenfeldt, J., Porse, B., Bone marrow-derived macrophages (BMM): isolation and applications. Cold Spring Harb. Protoc. 2008, 2008.
29. Festuccia, W. T., Blanchard, P.-G. G., Belchior, T., Chimin, P. et al., PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats. Am. J. Physiol. Endocrinol. Metab. 2014, 306, 54.
30. Sato, A., Kawano, H., Notsu, T., Ohta, M. et al., Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 2010, 59, 2495-2504.
31. Janovská, P., Flachs, P., Kazdová, L., Kopecký, J., Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis. Physiol. Res. 2013, 62, 153-161.
32. White, P. J., Arita, M., Taguchi, R., Kang, J. X., Marette, A., Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes 2010, 59, 3066-3073.
33. Sapieha, P., Stahl, A., Chen, J., Seaward, M. R. et al., 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci. Transl. Med. 2011, 3.
34. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J. et al., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α andγ. Proc. Natl. Acad. Sci. 1997, 94, 4318-4323.
35. Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A. et al., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-[gamma]. Nature 2005, 437, 759-763.
36. Mori, T. A., Woodman, R. J., Burke, V., Puddey, I. B. et al., Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic. Biol. Med. 2003, 35, 772-781.
37. Leesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E. et al., Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 2002, 41, 6640-6650.
38. Jung, U. J., Torrejon, C., Chang, C. L., Hamai, H. et al., Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2929-2937.
39. Leyvraz, C., Suter, M., Verdumo, C., Calmes, J. M. M. et al., Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation. Diabetes Obes. Metab. 2010, 12, 195-203.
40. van Ginderachter, J. A., Meerschaut, S., Liu, Y., Brys, L. et al., Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 2006, 108, 525-535.
41. Festuccia, W. T., Laplante, M., Brûlé, S., Houde, V. P. et al., Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation. J. Mol. Cell. Cardiol. 2009, 47, 85-95.
42. Festuccia, W., Blanchard, P.-G., Turcotte, V., Laplante, M. et al., The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296, 35.
43. Draper, E., Reynolds, C. M., Canavan, M., Mills, K. H., Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ. J. Nutr. Biochem. 2011, 22, 784-790.
44. Zhang, M., Fritsche, K. L., Fatty acid-mediated inhibition of IL-12 production by murine macrophages is independent of PPARγ. Br. J. Nutr. 2004, 91, 733-739.
45. Yore, M. M., Syed, I., Moraes-Vieira, P. M., Zhang, T. et al., Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 2014, 159, 318-332.
46. Calder, P. C., Mechanisms of action of (n-3) fatty acids. J. Nutr. 2012, 142, 592S-599S.
47. Arita, M., Bianchini, F., Aliberti, J., Sher, A. et al., Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 2005, 201, 713-722.